2024 ESMO Congress Preview for Medical Oncologists: The Show and After Show
September 10th 2024OncLive co-hosts Kristie L. Kahl and Andrew Svonavec highlight abstracts for medical oncologists to look out for at the upcoming ESMO Congress in Barcelona, with some additional tidbits to round out the main event.
Read More
FDA Approval Insights: Nirogacestat in Progressing Desmoid Tumors Requiring Systemic Treatment
January 15th 2024Dr Kasper discusses the FDA approval of nirogacestat for patients with progressing desmoid tumors; key efficacy, safety, and quality-of-life outcomes from the pivotal DeFi trial; and findings from an analysis investigating tumor volume and T2 hyperintensity changes with nirogacestat in patients enrolled in DeFi.
Read More